I wonder whether the last validation run, not the group of 160 runs, was in regard to the original runs, or whether they wanted a sample of Coronavirus for the substitute of Ebola? If that is the case then the claims would include Ebola-like viruses and would strengthen the application. That would be a good thing. Unfortunately, time keeps clicking along and we can't even get to marketing and sales.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.